Tangible Shareholders Equity: The value shareholders equity less intangible assets.
Adial Pharmaceuticals, Inc. (ADIL) had Tangible Shareholders Equity of $5.27M for the most recently reported fiscal year, ending 2025-12-31.
| Income Statement Financials | |
-- |
|
$-7.98M |
|
-- |
|
-- |
|
$7.80M |
|
$-7.80M |
|
$-0.18M |
|
$-7.98M |
|
$-7.98M |
|
$-7.98M |
|
$-7.98M |
|
$-7.98M |
|
$-7.98M |
|
$-7.80M |
|
$-7.80M |
|
0.67M |
|
0.67M |
|
$-11.93 |
|
$-11.93 |
|
| Balance Sheet Financials | |
$6.18M |
|
-- |
|
$0.49M |
|
$6.67M |
|
$1.40M |
|
-- |
|
-- |
|
$1.40M |
|
$5.28M |
|
|
Tangible Shareholders Equity |
$5.27M |
$5.28M |
|
1.11M |
|
| Cash Flow Statement Financials | |
$-6.49M |
|
$0.15M |
|
$8.47M |
|
$3.75M |
|
$5.88M |
|
$2.13M |
|
$0.68M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
4.42 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-6.34M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-151.18% |
|
-151.26% |
|
-119.54% |
|
-151.18% |
|
$4.75 |
|
$-9.49 |
|
$-9.71 |
|